Sailaja Puttagunta

2022 - Iterum Therapeutics plc

In 2022, Sailaja Puttagunta earned a total compensation of $755.9K as Chief Medical Officer at Iterum Therapeutics plc, a 36% decrease compared to previous year.

Compensation breakdown

Bonus$86,000
Non-Equity Incentive Plan$192,375
Salary$475,000
Other$2,519
Total$755,894

Puttagunta received $475K in salary, accounting for 63% of the total pay in 2022.

Puttagunta also received $86K in bonus, $192.4K in non-equity incentive plan and $2.5K in other compensation.

Rankings

In 2022, Sailaja Puttagunta's compensation ranked 3,616th out of 5,736 executives tracked by ExecPay. In other words, Puttagunta earned more than 37.0% of executives.

ClassificationRankingPercentile
All
3,616
out of 5,736
37th
Division
Manufacturing
2,057
out of 3,125
34th
Major group
Chemicals And Allied Products
988
out of 1,416
30th
Industry group
Drugs
925
out of 1,317
30th
Industry
Pharmaceutical Preparations
673
out of 963
30th
Source: SEC filing on March 16, 2023.

Puttagunta's colleagues

We found two more compensation records of executives who worked with Sailaja Puttagunta at Iterum Therapeutics plc in 2022.

2022

Corey Fishman

Iterum Therapeutics plc

Chief Executive Officer

2022

Judith Matthews

Iterum Therapeutics plc

Chief Financial Officer

News

You may also like